Patients with MI and COVID-19 had significantly higher levels of peak NT-proBNP, but there were no differences in peak hs cTn and peak creatinine during the hospital stay when compared to patients with non-COVID-19 MI. This evidence concerns the gene NPPB and COVID-19.